Morgan Stanley broker lists 60,000-share SYRE resale (SYRE)

Rhea-AI Filing Summary

Morgan Stanley Smith Barney LLC filed a Form 144 disclosing proposed sales of 60,000 common shares of SYRE, linked to previously exercised stock options dated 06/15/2023. The filing records completed 10b5-1 sales of 15,000 shares on 01/02/2026 and 15,000 shares on 02/02/2026, with proceeds of $460,114.50 and $492,069.00, respectively.

Insights

Insider Transactions Specialist

Form 144 shows a proposed resale of 60,000 SYRE shares and two recent 10b5-1 sales of 15,000 shares each.

The filing lists a 60,000 share proposed sale tied to stock options exercised on 06/15/2023. It also documents two executed 10b5-1 sales: 15,000 shares on 01/02/2026 for $460,114.50 and 15,000 shares on 02/02/2026 for $492,069.00.

Timing and cash‑flow treatment for the proposed 60,000 share sale are not specified beyond the exercise date; subsequent filings will show actual transaction settlement details.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	60000	2580600.00	78540164	03/02/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	06/15/2023	Previously Exercised Stock Options	Issuer			60000	06/15/2023	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for CAMERON W TURTLE 221 Crescent Street Building 23 Suite 105 Waltham MA 02453	Common	02/02/2026	15000	492069.00
10b5-1 Sales for CAMERON W TURTLE 221 Crescent Street Building 23 Suite 105 Waltham MA 02453	Common	01/02/2026	15000	460114.50

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Form 144 for SYRE disclose?

The Form 144 discloses a proposed resale of 60,000 common shares tied to stock options exercised on 06/15/2023. It also records two executed 10b5-1 sales of 15,000 shares each on 01/02/2026 and 02/02/2026.

How many shares were sold under 10b5-1 plans recently for SYRE?

The filing shows two recent 10b5-1 transactions: 15,000 shares sold on 01/02/2026 and 15,000 shares sold on 02/02/2026, totaling 30,000 shares sold in the past three months as listed.

What proceeds were reported from the recent 10b5-1 sales for SYRE?

Proceeds reported were $460,114.50 for the 01/02/2026 sale of 15,000 shares and $492,069.00 for the 02/02/2026 sale of 15,000 shares, as stated in the filing.

Who is the selling broker or arranger listed on the Form 144?

The filing lists Morgan Stanley Smith Barney LLC at 1 New York Plaza, 8th Floor as the broker/arranger for the transaction and identifies the issuer relation to previously exercised options dated 06/15/2023.

Are the 60,000 shares already sold or only proposed?

The filing describes a proposed sale of 60,000 common shares tied to exercised options on 06/15/2023. The document also separately lists two completed 10b5-1 sales of 15,000 shares each in January and February 2026.